pharmaceutical testing – Page 4

Problems with validating capsule release testing equipment.

Problems with validating capsule release testing equipment. Problems with Validating Capsule Release Testing Equipment Introduction: In the pharmaceutical industry, ensuring the consistent and reliable release of active pharmaceutical ingredients (APIs)…

Poor validation of analytical methods for capsule testing.

Poor validation of analytical methods for capsule testing. Poor validation of analytical methods for capsule testing. Introduction: The validation of analytical methods is a critical component of pharmaceutical development and…

Inadequate systems for monitoring capsule release profiles.

Inadequate systems for monitoring capsule release profiles. Inadequate systems for monitoring capsule release profiles. Introduction: The pharmaceutical industry is a cornerstone of modern healthcare, where ensuring the efficacy and safety…

Challenges in testing soft gelatin capsules with high oil content.

Challenges in testing soft gelatin capsules with high oil content. Challenges in testing soft gelatin capsules with high oil content Introduction: Soft gelatin capsules are a popular dosage form in…

Problems with detecting changes in gelatin plasticizer levels during stability testing.

Problems with detecting changes in gelatin plasticizer levels during stability testing. Problems with Detecting Changes in Gelatin Plasticizer Levels During Stability Testing Introduction: In the pharmaceutical industry, solid oral dosage…

Poor reproducibility in disintegration testing for coated capsules.

Poor reproducibility in disintegration testing for coated capsules. Poor reproducibility in disintegration testing for coated capsules Introduction: In the pharmaceutical industry, disintegration testing is a critical quality control measure that…

Addressing Color Changes in Film-Coated Tablets During Stability Studies

Addressing Color Changes in Film-Coated Tablets During Stability Studies Addressing Color Changes in Film-Coated Tablets During Stability Studies Introduction: In the pharmaceutical industry, maintaining the integrity and appearance of film-coated…

Problems with testing capsules containing high API load.

Problems with testing capsules containing high API load. Problems with testing capsules containing high API load. Introduction: In the pharmaceutical industry, capsules are a popular solid oral dosage form due…

Inadequate validation of capsule disintegration profiles for multi-particulate capsules.

Inadequate validation of capsule disintegration profiles for multi-particulate capsules. Inadequate validation of capsule disintegration profiles for multi-particulate capsules. Introduction: In the pharmaceutical industry, the validation of capsule disintegration profiles is…

Inadequate methods for evaluating capsule dissolution in biorelevant media during stability studies.

Inadequate methods for evaluating capsule dissolution in biorelevant media during stability studies. Inadequate methods for evaluating capsule dissolution in biorelevant media during stability studies. Introduction: In the realm of pharmaceuticals,…

Problems with predicting the stability of capsules containing sensitive APIs.

Problems with predicting the stability of capsules containing sensitive APIs. Problems with Predicting the Stability of Capsules Containing Sensitive APIs Introduction: In the pharmaceutical industry, ensuring the stability of drug…

Challenges in testing capsules with delayed-release profiles.

Challenges in testing capsules with delayed-release profiles. Challenges in testing capsules with delayed-release profiles. Introduction: Delayed-release capsules are a crucial innovation in pharmaceutical science, allowing for the targeted delivery of…